ArticleCureus2025
Secondary Cicatricial Scalp Alopecia Caused by Brunsting-Perry Pemphigoid: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brunsting-Perry pemphigoid is a rare, chronically persistent bullous dermatosis, localized to the head, scalp, and neck, causing residual scars and cicatricial alopecia. Herein, we present a case of Brunsting-Perry pemphigoid in a 68-year-old Caucasian woman presenting with over 10 years of history of slowly progressing patchy cicatricial alopecia. Dermoscopy showed scarring, a milky red background, and a typical picture of a "fried-egg sign" representing specific follicular damage. A skin biopsy revealed a subepidermal blister with dermal inflammation. Immunopathology shows strong linear continuous deposits of C3c and IgM along the basement membrane, and moderate to weak linear reactions to IgG and IgA. Intralesional betamethasone was successful in the treatment, and topical mometasone furoate lotion was used to maintain the result. Our case suggests that Brunsting-Perry pemphigoid may be underdiagnosed as the reason for scarring alopecia, considering the scarce information about the disease in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.